2014
Reduced Fluorescein Angiography and Fundus Photography Use in the Management of Neovascular Macular Degeneration and Macular Edema During the Past DecadeImaging Tests for Macular Diseases
Schneider EW, Mruthyunjaya P, Talwar N, Nwanyanwu K, Nan B, Stein JD. Reduced Fluorescein Angiography and Fundus Photography Use in the Management of Neovascular Macular Degeneration and Macular Edema During the Past DecadeImaging Tests for Macular Diseases. Investigative Ophthalmology & Visual Science 2014, 55: 542-549. PMID: 24346174, PMCID: PMC3907135, DOI: 10.1167/iovs.13-13034.Peer-Reviewed Original ResearchConceptsNeovascular age-related macular degenerationProportion of patientsMacular edemaFluorescein angiographyFundus photographyOptical coherence tomographyMacular degenerationDiagnostic testingIncident neovascular age-related macular degenerationAge-related macular degenerationRepeated-measures logistic regressionNeovascular macular degenerationTraditional diagnostic testingUse of OCT
2013
Cost-Effectiveness of Various Interventions for Newly Diagnosed Diabetic Macular Edema
Stein JD, Newman-Casey PA, Kim DD, Nwanyanwu KH, Johnson MW, Hutton DW. Cost-Effectiveness of Various Interventions for Newly Diagnosed Diabetic Macular Edema. Ophthalmology 2013, 120: 1835-1842. PMID: 23642372, PMCID: PMC3737388, DOI: 10.1016/j.ophtha.2013.02.002.Peer-Reviewed Original ResearchMeSH KeywordsAngiogenesis InhibitorsAntibodies, Monoclonal, HumanizedBevacizumabCombined Modality TherapyCost-Benefit AnalysisDiabetic RetinopathyDiagnostic Techniques, OphthalmologicalDrug CostsFinancing, PersonalGlucocorticoidsHealth Care CostsHumansIntravitreal InjectionsLaser CoagulationMacular EdemaMarkov ChainsMiddle AgedQuality-Adjusted Life YearsRanibizumabTriamcinolone AcetonideVascular Endothelial Growth Factor AConceptsQuality-adjusted life yearsProbabilistic sensitivity analysesTime horizonSensitivity analysisCost-effectiveness analysisWTP valuesCost-effective treatment optionLife yearsIncremental costMedicare fee scheduleWTPHypothetical cohortFee scheduleCSDMECostHorizonFinancialMarkov modelWillingnessOptions